Amersham Biosciences' IN Cell Analyzer Delivers Outstanding Results for AstraZeneca.Business Editors & Health/Medical Writers BIOWIRE2K NOTE: Multimedia assets available PISCATAWAY, N.J.--(BW HealthWire)--June 19, 2002 Amersham Biosciences: IN Cell Analyzer Enables Scientists to Study Drug Activity in Living Cells in Real Time Amersham Biosciences, the life sciences business of Amersham plc Amersham plc was a UK pharmaceutical company, specializing in medical diagnostics and life science products. The company was formed in 1997 by merging Amersham International (U.K.), Pharmacia Biotech (Sweden) and Nycomed (Norway). (LSE LSE - Language Sensitive Editor : NYSE NYSE See: New York Stock Exchange : OSE OSE - Open Systems Environment : AHM AHM Automated Hacking Machines AHM All Hands Meeting AHM Academy for Healthcare Management AHM Atom Heart Mother (Pink Floyd album) AHM Airport Handling Manual AHM Acutely Hazardous Material AHM Anti-Helicopter Mine ) today announced that its IN Cell Analyzer system for cellular screening is delivering outstanding results for U.K.-based global pharmaceutical company AstraZeneca, one of the system's first triallists. AstraZeneca has already committed to taking delivery of two IN Cell Analyzer systems during the fourth quarter of 2002. "We have been working with the IN Cell Analyzer for several months, and we have been very impressed by its powerful cellular imaging capabilities and sophisticated software tools," said Elaine Sullivan, Ph.D., Director of The Advanced Science and Technology Laboratory at AstraZeneca. "The system is allowing our scientists to probe deep inside a living cell and evaluate directly the effects of a drug compound on cellular processes in real time." Amersham Biosciences created the IN Cell Analyzer in response to increasing demand for technologies that would enable testing of potential new drugs directly in cells--called cell-based assays. The system's innovative detection technology permits sub-cellular imaging and the analysis of nearly 400 assays in as little as 15 minutes and of over 10,000 cellular images in eight hours. At the heart of the IN Cell Analyzer is a proprietary, laser-based, confocal confocal see confocal microscopy. imaging system that includes three high-speed cameras. "The exquisite sensitivity and unsurpassed analytical speed of the IN Cell Analyzer enables researchers to view cell function in real time and to observe the biological changes that occur when a drug compound enters the cell," said Mike Evans, Ph.D., Vice President of Bioassays at Amersham Biosciences. "It provides powerful imaging technology in an easy-to-use system that greatly enhances the speed and performance of cellular screening for drug discovery." Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Its systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technologies are pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. and research and academic institutions, principally in North America, Europe, Latin America and Asia. For more information, please visit www.amershambiosciences.com. AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $16.4 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia anaesthesia anesthesia. (including pain management), cardiovascular, central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) and respiratory products. Amersham Biosciences--enabling molecular medicine Note: A Photo is available at URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. : http://www.businesswire.com/cgi-bin/photo.cgi?pw.061902/bb2 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion